PRLD: Breakthroughs in POC diagnostics and IP, but future hinges on successful rights issue

About this update from Prolight Diagnostics Ab

Prolight Diagnostics advanced its Psyros POC system toward commercialization in 2024, supported by positive preclinical data, new patents, and SEK 22.4 million in warrant funding, but remains pre-revenue and dependent on a critical rights issue for continued operations.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Prolight Diagnostics Ab